| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | +15.0% |
| Cost of Revenue | $4.1M | +8.4% |
| Gross Profit | $1.1M | +48.1% |
| R&D Expense | $7.8M | +51.4% |
| SG&A Expense | $8.4M | +12.8% |
| Operating Income | -$18.7M | -27.2% |
| Pre-tax Income | -$18.5M | -24.1% |
| Income Tax | $28K | -37.8% |
| Net Income | -$18.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -61.4% |
| Accounts Receivable | $1.0M | -15.5% |
| Inventory | $1.6M | +41.8% |
| Current Assets | $21.3M | -42.5% |
| Total Assets | $24.7M | -37.9% |
| Current Liabilities | $5.1M | +16.6% |
| Total Liabilities | $7.3M | +17.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.5M | -17.7% |
| Capital Expenditures | $473K | +37.5% |
| Investing Cash Flow | $8.4M | +137.6% |
| Financing Cash Flow | -$140K | -100.4% |
| Free Cash Flow | -$16.0M | -18.2% |
| -24.0% |
| EPS (Basic) | -$2.35 | -15.8% |
| Stockholders' Equity |
| $17.4M |
| -48.1% |